Back to search

Article

Novel engineered chimeric engulfment receptors trigger T-cell effector functions against SIV infected CD4+ T cells

2022-06-25

Abstract excerpt

<h4>ABSTRACT</h4> Adoptive therapy with genetically engineered T cells offers potential for infectious disease treatment in immunocompromised persons. HIV/simian immunodeficiency virus (SIV) infected cells express phosphatidylserine (PS) early post-infection. We tested whether chimeric engulfment receptor (CER) T cells designed to recognize PS-expressing cells could eliminate SIV infected cells. Lentiviral CER co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1f6c4bf0-0bee-5361-9e4a-2d2f087263e2
DOI
10.1101/2022.06.21.495546
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel engineered chimeric engulfment receptors trigger T-cell effector functions against SIV infected CD4+ T cellsDOI 10.1101/2022.06.21.495546
Select a neighboring publication to make it the new centre.